- Book
- November 2018
- 296 Pages
- Book
- May 2025
- 1104 Pages
- Book
- April 2024
- 448 Pages
- Book
- August 2023
- 368 Pages
- Book
- September 2022
- 304 Pages
- Book
- August 2022
- 736 Pages
- Book
- January 2022
- 720 Pages
- Book
- February 2020
- 448 Pages
- Book
- December 2019
- 432 Pages
- Book
- November 2019
- 432 Pages
- Book
- July 2018
- 304 Pages
- Book
- January 2016
- 952 Pages
- Book
- April 2012
- 776 Pages
- Book
- November 2011
- 432 Pages
- Book
- August 2011
- 466 Pages
- Book
- October 2010
- 606 Pages
€2204EUR$2,492USD£1,925GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more